Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01760525
Title A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Age Groups: adult
Covered Countries USA | FRA | DEU

Facility Status City State Zip Country Details
Dana Farber Cancer Institute SC (2) Boston Massachusetts 02215 United States Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Zuerich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from for the field